scispace - formally typeset
P

Peter G. Gibson

Researcher at University of Newcastle

Publications -  774
Citations -  53254

Peter G. Gibson is an academic researcher from University of Newcastle. The author has contributed to research in topics: Asthma & Sputum. The author has an hindex of 103, co-authored 711 publications receiving 45722 citations. Previous affiliations of Peter G. Gibson include University of Sydney & National Health and Medical Research Council.

Papers
More filters
BookDOI

Evidence-based respiratory medicine /

Peter G. Gibson, +5 more
TL;DR: Evidence-based respiratory medicine, a meta-analysis of existing evidence, shows clear trends in prognosis and prognosis for smoking cessation in patients with smoking-related illnesses.
Journal ArticleDOI

Pulmonary manifestations of the acquired immunodeficiency syndrome.

Peter G. Gibson, +5 more
- 01 Dec 1987 - 
TL;DR: Pneumocystis carinii pneumonia (PCP) is a common pulmonary manifestation in patients with AIDS which is treatable and has an initially favourable outcome.
Journal ArticleDOI

Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria

Mark Hew, +32 more
- 01 Nov 2016 - 
TL;DR: Omalizumab (Xolair) dosing in severe allergic asthma is based on serum IgE and bodyweight and about 62% of patients receiving government‐subsidized omalizuab are enrolled in the Australian Xolair Registry (AXR).
Journal ArticleDOI

Variability of blood eosinophils as a biomarker in asthma and COPD.

Peter G. Gibson
- 01 Jan 2018 - 
Journal ArticleDOI

Resistin is a predictor of asthma risk and resistin:adiponectin ratio is a negative predictor of lung function in asthma

Danielle Ballantyne, +6 more
- 01 Aug 2016 - 
TL;DR: Adipokines, such as resistin and adiponectin, modify inflammation and may contribute to increased asthma risk and severity in obese people.